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Abstract
Large-scale cancer genome projects, such as the Cancer Genome Atlas (TCGA) project, are comprehensive molecular
characterization efforts to accelerate our understanding of cancer biology and the discovery of new therapeutic targets. The
accumulating wealth of multidimensional data provides a new paradigm for important research problems including cancer
subtype discovery. The current standard approach relies on separate clustering analyses followed by manual integration.
Results can be highly data type dependent, restricting the ability to discover new insights from multidimensional data. In
this study, we present an integrative subtype analysis of the TCGA glioblastoma (GBM) data set. Our analysis revealed new
insights through integrated subtype characterization. We found three distinct integrated tumor subtypes. Subtype 1 lacks
the classical GBM events of chr 7 gain and chr 10 loss. This subclass is enriched for the G-CIMP phenotype and shows
hypermethylation of genes involved in brain development and neuronal differentiation. The tumors in this subclass display
a Proneural expression profile. Subtype 2 is characterized by a near complete association with EGFR amplification,
overrepresentation of promoter methylation of homeobox and G-protein signaling genes, and a Classical expression profile.
Subtype 3 is characterized by NF1 and PTEN alterations and exhibits a Mesenchymal-like expression profile. The data
analysis workflow we propose provides a unified and computationally scalable framework to harness the full potential of
large-scale integrated cancer genomic data for integrative subtype discovery.
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Introduction
Cancer genomes harbor a plethora of somatically acquired
aberrations. DNA copy number aberrations are key characteristics
of cancer, contributing to genomic instability and gene deregula-
tion [1,2] such as oncogene activation by gene amplification or
tumor suppressor loss as a result of gene deletion. Epigenetic
aberrations such as DNA methylation are also widespread in the
cancer genome [3]. Genome-wide hypomethylation causes
genome instability, and hypermethylation of CpG islands has
been associated with inactivation of tumor suppressor genes. Many
of these genomic changes in the DNA may affect the expression
level of messenger RNA (mRNA) as well as non-coding
microRNAs, alter the function of the gene product, and ultimately
lead to abnormal cellular and biological functions that contribute
to tumorigenesis.
Large-scale cancer genome projects including the Cancer
Genome Atlas (TCGA) and the International Cancer Genome
Consortium (ICGC) are generating an unprecedented amount of
multidimensional data using high resolution microarray and next-
generation sequencing platforms. With the accumulating wealth of
multidimensional data, there is a great need for methods geared
toward integrative analysis of multiple genomic data sources. New
methods for this type of analysis have been developed. Several
recent studies consider pathway and network analysis using
multidimensional data [4,5]. A number of others [6–11] suggest
using canonical correlation analysis (CCA) to quantify the
correlation between two data sets (e.g., gene expression and copy
number data). None of these methods are specifically designed for
tumor subtype analysis in an integrative fashion.
The clinical and therapeutic implications for many existing
molecular subtypes of cancer remain largely unknown. Prioritiza-
tion of candidate markers relies to a great extent on existing
knowledge of cancer biology. To that end, integrating multiple
data types (e.g., copy number and gene expression) can provide
key information to pinpoint the genomic alterations that
characterize disease subtypes of biological and clinical importance
(e.g., HER2 oncogene activation through concordant DNA
amplification and mRNA overexpression). Individually, none of
the data types completely capture the complexity of the cancer
genome or precisely pinpoint the cancer driving mechanism.
Collectively, however, integrative genomic studies provide a new
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associated cancer genes.
The current standard analysis involves separate clustering of
different genomic data types followed by a manual integration of
the cluster assignments. Results can be highly data type
dependent, restricting the ability to discover additional insights
from multidimensional data. Correlation between data types
cannot be utilized in a separate clustering approach, causing
substantial loss of information. Another challenge with standard
clustering algorithms is that feature selection is not part of the
clustering procedure. Typically, all features that pass some initial
variance filtering step are included for clustering. The result can be
high variable due to noise accumulation in estimating the
population cluster centroids in high dimensional feature space.
An example can be seen in Supplementary Figure S1E. As a result,
sparse clustering has generated much attention in recent statistical
literature [12–16], assuming a small fraction of the features are
directly relevant for class discovery. Statistical inference in high
dimensional data setting becomes more reliable with the sparsity
assumption. Correct selection of the class-discriminant features
crucially affects model interpretation, statistical accuracy, and
computational complexity. Yet most widely applied clustering
methods are decoupled from the procedure of selecting cluster-
discriminant features.
In a previous publication [17], we introduced an integrative
clustering method called iCluster based on a Gaussian latent
variable model with lasso [18] type penalty terms to induce
sparsity in the coefficient matrices toward feature selection. In this
paper, we present an integrative analysis workflow using iCluster
and demonstrate its utility in defining molecular subtypes of
glioblastoma multiforme (GBM) by simultaneously clustering
genome-wide DNA copy number, methylation, and gene
expression data derived from the TCGA GBM samples. We
implemented a modified algorithm using a variance weighted
penalty term that is proportional to the error variance associated
with each feature. As a result, coefficients will be more heavily
penalized for features demonstrating high variance. We discuss the
details of the weighted shrinkage estimates in the Methods Section.
Results
A unified framework for clustering, data integration,
dimension reduction, and feature selection
Supplementary Figure S1 illustrates the workflow of an
integrative clustering analysis. The iCluster method simultaneous-
ly achieves data integration and dimension reduction through a
joint latent variable model. The goal is to identify a set of driving
factors that define biologically and clinically relevant subtypes of
the disease. This is best explained by an example. In the well-
known HER2 breast tumor subtype, the driving characteristic of
the subtype is the HER2 oncogene activation through concordant
DNA amplification and mRNA overexpression of genes within the
HER2 amplicon (Supplementary Figure S1D). Based on existing
knowledge on the driving factors (HER2 in this case) in a certain
cancer type and the observed data for each tumor, we can model
the patients’ multidimensional genomic profile as functions of the
driving factors for effective data integration and dimension
reduction. However, in the general problem of class discovery,
the driving factors are not known and need to be identified from
the multidimensional data space. This motivates us to consider a
latent variable modeling framework.
The model induces complex dependence structures among
different genomic data types using latent variables that represent
the underlying cancer driving factors. Integration and dimension
reduction is achieved through simultaneous projection of the
multidimensional data space of different dimensions and scales
onto a lower dimensional latent subspace of unified dimension and
scale (Figure 1). The resulting latent subspace reveals cluster
structures among the sample points. The coefficient matrix
determines the relationship between the original features and the
latent variable. A variance-weighted adaptive shrinkage method is
applied to impose sparsity on the loading matrix (many entries are
zero) for selecting cluster-discriminant features as part of the
iCluster procedure. Revisiting the HER2 subtype example, the
loading vector associated with the HER2 subtype will only have
nonzero values for genes within the HER2 amplicon and zeros
everywhere else (Supplementary Figure S1F).
Comparison to separate clustering and naive integration
using simulation
Separate clustering followed by manual integration remains the
most frequently applied approach to analyze multiple omics data
sets in the current literature for its simplicity and the lack of a truly
integrative approach. Using simulation analysis, we demonstrate
that separate clustering can fail drastically in estimating the true
number of clusters, classifying samples to the correct clusters, and
selecting cluster-associated features. In Table 1, the simpler
method (separate K-means) chooses the correct number of clusters
(k) only 60% of the time with an average cluster reproducibility of
0.68. By contrast, iCluster estimates the correct number of clusters
90% of the time with an average cluster reproducibility of 0.81. In
a second simulation scenario with a more sparse data structure in
which only two features are relevant to define the clusters, the
iCluster method outperforms the competing approach by a
substantial margin in terms of the ability to choose the correct
number of clusters (40% vs 92% accurate), cross-validated error
rates (0.11 vs 0.01), and cluster reproducibility (0.48 vs 0.98)
(Simulation Scenario 2 in Table 1). This simulation analysis
indicates that care should be taken in the current standard practice
when interpreting results from separate clustering of multidimen-
sional data sets.
We also compared iCluster to a principal component analysis
(PCA) based integration. PCA is known to reveal cluster structures
in a lower dimensional latent subspace. Given multiple data types,
we applied PCA to the combined data matrices. Using simulated
data, Figure 2 shows that such naive integration cannot separate
the subgroups with high accuracy. By contrast, iCluster clearly
outperforms the naive integration as well as the separate
clusterings in discriminating the true clusters.
iCluster Identifies Three Distinct Molecular Subtypes of
Glioblastoma
In recent TCGA publications on glioblastoma subtypes,
Verhaak et al. (2010) [19] identified four distinct expression
subtypes: Proneural, Neural, Classical and Mesenchymal using
1,740 most variable genes. In addition, Noushmehr et al. (2010)
[20] reported a Glioma-CpG Island Methylator Phenotype (G-
CIMP) based on 1,503 methylation features. We hypothesize that
an integrative subtype analysis would be a more powerful
approach to characterize subtypes with coordinated genomic,
epigenomic, and transcriptomic alterations. To that end, we
applied the iCluster algorithm for a joint analysis of copy number,
methylation and gene expression on a subset of 55 glioblastoma
samples (see Data Set Section).
The number of reproducible subtypes (K) and model sparsity
(number of subtype-discriminant features) are determined using a
resampling-based scheme as described in the Methods Section.
iCluster
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is computed for each point drawn from the parameter space based
on a uniform sampling design. An RI close to 1 indicates perfect
cluster reproducibility and an RI close to 0 indicates poor
reproducibility. Table 2 indicates highly reproducible solutions by
integrative clustering. Both K=2 and K=3 are highly reproduc-
ible with RI=1.00 and 0.93 respectively. We further examine the
cluster separability plots (see Methods) in Figure 3, which reveals
that K=3 gives the best diagonal block structure. Overall, we find
combining the cluster reproducibility and separability measure is
an effective way for choosing the number of clusters given complex
data structures. In Figure 4, iCluster outperforms the competing
methods in revealing subgroup structure in the lower dimension
latent subspace. The standard PCA and a sparse PCA approach
[9] applied to the concatenated data matrix did not achieve
satisfactory results (Figure 4B and 4C).
Figure 5 reveals the major characteristics for each of the three
integrated GBM subtypes. The most notable feature of the
Glioblastoma subtype 1 identified by iCluster is the lack of chr7
gain and chr10 loss (the classical GBM events), and shows a
‘‘sporadic’’ profile of copy number alterations. This subclass is
enriched for the G-CIMP phenotype and shows hypermethylation
of genes involved in brain development and neuronal differenti-
ation including DLC1, JAG2, and ALDH1A3 (Supplementary Table
S1). The expression phenotype of the tumors in this subclass is
predominantly Proneural. This subclass of patients show signifi-
cantly better survival (P=0.01) than the other two clusters
(Figure 6). Subtype 2 is characterized by a near complete
association with EGFR amplification, gains of chr 19 and 20,
methylation of homeobox genes including IRX2 and BARHL2 and
G-protein signaling genes including CXCL6 and DRD5, and a
classical-enriched expression profile. Subtype 3 is characterized by
NF1 and PTEN alterations and exhibits mesenchymal-like
expression.
Joint feature selection reveals coordinated genomic and
epigenomic regulation
As mentioned earlier, feature selection is an integral part of the
iCluster algorithm and is accomplished via an adaptive shrinkage
estimation of the coefficient matrix. A genomic feature is
associated with a subtype if the corresponding shrinkage-based
coefficient (factor lading) estimate is nonzero. As a result,
clustering variability can be substantially reduced by effectively
removing noninformative features by forcing their coefficients to
zero. As mentioned earlier, Table 1 clearly shows that the sparse
models, as a result, lead to significantly better cluster reproduc-
ibility than their nonsparse counterparts. The performance of the
latter using all features is degraded by noise accumulation. The full
lists of selected features arranged in the corresponding gene cluster
can be found in Supplementary Tables S1 and S2.
Mutual information I(X,Y) is a measure of dependence between
two random variables that is considered more general and robust
than correlation. It is a nonnegative measure with I(X,Y)=0
indicating independence. [21] used mutual information to quantify
on a global level the extent to which entropy increase in one
random variable (DNA copy number) leads to an entropy increase
in another (gene expression). Figure 7 shows the distribution of all
pair-wise mutual information between DNA methylation and gene
Figure 1. The iCluster framework.
doi:10.1371/journal.pone.0035236.g001
Table 1. Comparing separate clustering and iCluster performance using simulation.
Simulated Scenario 1
Method Freq estimating the correct K Error Rate RI
Separate K-means 60% 0.08 (0.04) 0.68 (0.18)
Sparse iCluster 90% 0.04 (0.02) 0.81 (0.08)
Simulated Scenario 2
Separate K-means 40% 0.11 (0.06) 0.48 (0.20)
Sparse iCluster 92% 0.01 (0.01) 0.98 (0.04)
Simulation scenario 1 consists of a pair of matched data sets of 200 features (20 of which are relevant to clustering and 180 are noisy features) in 100 samples belonging
to two distinct clusters. Scenario 2 represents an extremely sparse data structure with only 2 cluster-associated features and 198 noisy features. RI is the resampling-
based cluster reproducibility criterion and ranges between 0 and 1. A value close to 1 indicates perfect cluster reproducibility, and a value close to 0 indicates poor
reproducibility. Separate K-means has two sets of numbers associated with each criterion because of separate model fits. The numbers are similar and therefore
averaged in the table. The number in parentheses is the standard deviation over 50 simulations.
doi:10.1371/journal.pone.0035236.t001
iCluster
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expression (7B). The unselected feature space (all features) is
dominated by features with low mutual information content,
whereas the iCluster selected feature space is substantially enriched
for features with high mutual information content with the
distribution considerably shifted to the right.
Discussion
Integrative genomic studies given multiple omic dimensions
carry the promise of more power to characterize, classify, and
predict outcomes in cancer than the conventional genomic study
involving gene expression data alone. We present a unified data
analysis framework that conducts clustering, data integration,
feature selection, and dimension reduction simultaneously to
harness the full potential of large-scale integrated cancer genomic
data. As we illustrated using the TCGA GBM data set, a strength
of an integrative clustering analysis is the ability to discover and
visualize coordinated patterns of genomic alterations, providing a
biologically comprehensive context for subtype discovery.
A practical challenge for validating integrated clusters is the
availability of independent data sets with all data types available.
With the accumulating number of integrated genomic profiling
studies, we expect this problem will become less severe over time.
In the GBM data set, each data type shows distinct cluster-
discriminating patterns (Figure 5). A natural question then arises as
to what degree a single data type (e.g., copy number) can
reproduce the integrated subtype label generated by iCluster. To
that end, we conducted an internal cross-validation (CV) based on
the copy number profile alone using a k-nearest neighbor method.
In leave-one-out cross-validation, we find the k nearest neighbors
of the left-out sample (based on the Euclidean distance of the copy
Figure 2. Comparing iCluster to a naive integration via PCA
using simulated data. Two-dimensional plots of the sample points in
the latent subspace by different methods. A set of 150 subjects are
simulated belonging to three clusters (indicated by black, blue, and
orange dots). Each subject has a pair of synthetic molecular profiles
representing two data types each consisting of 1,000 features. A
common set of 5 correlated features in both data type 1 and 2 defines
the black subtype. Another set of 5 features specific to data type 2
defines the blue subtype. The remaining features are noise.
doi:10.1371/journal.pone.0035236.g002
Figure 3. Cluster separability plots in the GBM data set.
Proportion of deviation (POD) is calculated as the proportion of
deviation from a block diagonal structure. K=3 has the best block-
diagonal structure.
doi:10.1371/journal.pone.0035236.g003
Table 2. Integrated subtype reproducibility and number of
subtype-discriminant features.
Reproducibility
Index CN features Methyl features Exp features
1.00 104 74 91
0.93 308 240 228
0.54 713 272 285
0.63 550 631 488
0.41 453 672 237
doi:10.1371/journal.pone.0035236.t002
iCluster
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corresponding class label with the majority votes. We iterate this
procedure until all the samples are left out once and assigned a
corresponding class label. The CV error rate is then computed as
the percentage of misclassified subtype memberships. The k
chosen is the one that minimizes this CV error rate. The
procedure can be similarly applied to other data types. Using this
internal cross-validation procedure, we found using copy number
data alone could assign 77% of the samples to the correct
integrated subtype. Through a similar procedure, we obtained an
87% accuracy using the expression data alone, and a 93%
accuracy using the methylation data alone for classifying the
samples to the correct integrated subtype label.
Given the reasonably good cross-validation performance, we
then applied this single data type validation approach using an
independent set of 136 samples from the same TCGA GBM
cohort that were not included in the integrative clustering analysis
for reasons discussed in Materials and Methods. We assigned
cluster membership for each of the 136 samples based on the
majority voting of the k-nearest neighbor approach based on copy
number profiles alone (Supplementary Figure S2) and based on
their gene expression profile alone (Supplementary Figure S3).
Both clearly indicate that the distinct copy number and gene
expression patterns in Figure 5 can be validated in the
independent sample set.
In general practice, a validation study requires the availability of
all data types used for the discovery of the integrated subtypes.
However, as we have shown here, an internal cross-validation can
be used to assess the degree to which each single data type alone
can reproduce the integrated cluster membership. If a single data
type can replicate the integrated subtypes with sufficient accuracy,
then it may not be necessary to collect all of the data types in
subsequent validation experiments.
Figure 4. Comparison of the iCluster method to PCA approaches in the GBM data set. Two-dimensional plots of the sample points in the
latent subspace spanned by A) the first two joint latent factors obtained using iCluster, B) the first two principal components (PCs) from the
concatenated data matrix, C) the first two sparse PCs from the concatenated data matrix, D) the first two PCs from the mRNA expression data alone,
E) from the copy number data alone, and F) from the methylation data alone.
doi:10.1371/journal.pone.0035236.g004
iCluster
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35236Figure 5. iCluster reveals three distinct glioblastoma integrated subtypes. iCluster was applied using 1,599 copy number features, 1,515
DNA methylation features, and 1,740 expression features. Heatmap display of the subset of cluster-discriminant features reveals highly coordinated
pattern of alteration in copy number, methylation, and expression. Integrated subtype 1 shows a ‘‘sporadic’’ profile of copy number alterations;
hypermethylation of genes involved in brain development and neuronal differentiation, and a proneural expression profile. Integrated subtype 2 is
characterized by a near complete association with EGFR alteration, gains of chr 19 and 20, methylation of homeobox genes, and a classical-enriched
iCluster
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Data set
A description of the TCGA data types, platforms and analyses
can be found in TCGA (2008). The GBM data set were
downloaded from the Cancer Genome Atlas public data portal,
and from the cBio Cancer Genomics Portal (http://cbioportal.
org/) at the Memorial Sloan-Kettering Cancer Center. For copy
number data (n=206), ‘‘level 3’’ normalized and segmented data
from Agilent 244 K CGH arrays were used. In a typically data
pre-processing step, we use CGHregion [22] to reduce multi-
sample array CGH data to 1 K–5 K unique regions. In this study,
however, we use the gene-centric data generated using RAE [23]
to facilitate interpretation and comparison with published results.
For mRNA expression data (n=202), unified gene expression data
across three microarray platforms (Affymetrix Human Exon 1.0
ST GeneChips, Affymetrix HT-HG-U133A GeneChips, and
custom designed Agilent 244 K array) as described in [19] were
used. A final set of 1,740 most variable genes were used for the
analysis. The GBM methylation data were generated on two
different platforms: Illumina Infinium and GoldenGate. We used
the higher resolution data from the Infinium 27 K platform in this
study (n=91). A set of 1,515 most variable probes (beta values)
were used for the analysis. The final ‘‘triplet’’ dataset for
integrative analysis (copy number, expression, methylation)
consists of a total of 55 samples where all three data types as
described above are available.
Sparse joint latent variable model
Suppose t~1,   ,m different genome-scale data types (DNA
copy number, methylation, mRNA expression, etc.) are obtained
in i~1,   ,n tumors. Let xit~(xi1t,   ,xiptt)’ denote a pt-
dimensional genomic data vector. Each element xijt,j~1,   ,pt,
represents the observation associated with the jth genomic feature
of type t measured in tumor i. To facilitate the discussion of
feature selection in this paper, we use genomic feature as a general
term to refer to protein-coding genes as well as non-coding genetic
and genomic elements depending on the platform and data type.
The details of the integrative clustering method can be found in
[17,24]. Briefly, the sets of m genomic data vectors fxtg
m
t~1 are
related to a common (shared) set of latent variables zi using the
following model
xit~Wtzizeit, i~1,   ,n; t~1,   ,m,
where Wt denotes the coefficient (loading) matrix associated with
data type t, and eit denotes the error term with mean zero and a
diagonal covariance matrix Yt~diag(s2
1t,   ,s2
ptt), representing
the residual variance.
The iCluster framework simultaneously achieves data integra-
tion and dimension reduction. The concept of the model is
depicted in Figure 1 and Supplementary Figure S1. The common
latent variable vector zi represents the underlying driving factors in
tumor i that can be used for disease subtype assignment. It is also a
key instrument for inducing complex dependence structures
between data types and as a result renders an effective integration
scheme across multiple correlated data sources. At the same time,
dimension reduction is achieved through projecting the multidi-
mensional data space to a low dimensional integrated subspace:
expression profile. Integrated subtype 3 is characterized by NF1 and PTEN alterations and exhibits mesenchymal-like expression. The TCGA
expression subtype and the G-CIMP subtype memberships are aligned on top of the integrated subtype membership as color-coded labels. PI3K
pathway activity is shown at the bottom of the figure.
doi:10.1371/journal.pone.0035236.g005
Figure 6. Kaplan-Meier plot. The three integrated subtypes of
glioblastoma identified by iCluster show survival differences.
doi:10.1371/journal.pone.0035236.g006
Figure 7. Mutual information.
doi:10.1371/journal.pone.0035236.g007
iCluster
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m
t~1?Z, where Xt~(x1t,   ,xnt) is the data matrix of
dimension pt|n and Z~(z1,   ,zn) is the latent factor matrix of
dimension g|n. Typically, g%
P
t pt, providing a low-rank joint
approximation to the original data sets. We assume a rank-g
approximation where g~K{1 for separating K clusters among
the n data points.
Parameter Estimation
The EM algorithm [25] is used for parameter estimation. Given
Gaussian error terms eit*N(0,Yt), the Expectation step (E-step)
entails computing the posterior mean and variance of the latent
factors, and the Maximization step (M-step) leads to estimates of
the coefficient matrix and the error covariance matrix. The
algorithm iterates between E-step and M-step until convergence.
Sparsity in the estimate of fWtg
m
t~1 are important for balancing
between model fit and model complexity. In the original paper
[17], we proposed to use a lasso approach that penalizes the ‘1
norm of the coefficient vectors and continuously shrinks the
coefficients associated with noninformative genes toward zero. Let
wjkt denote the element in row j and column k of the coefficient
matrix Wt, we considered the following shrinkage estimates:
w
(qz1)
jkt ~sign(~ w w
(q)
jkt) D~ w w
(q)
jktD{
lt
2
  
z
,
where w
(q)
jkt is the standard maximum likelihood estimates at the q-
th EM iteration, and (:)z denotes the positive part. When the
penalty parameter lt is sufficiently large, many of the coefficient
estimates will be exactly zero. If wjkt~0, feature j in data type t
has has no bearing on the kth latent factor. A sparse Wt with lots
of zero elements is more interpretable and provides a framework
for selecting cluster-discriminant features.
In this paper, we consider an adaptive-type penalty that is
proportional to the variance of each feature in the following form:
w
(qz1)
jkt ~sign(~ w w
(q)
jkt) D~ w w
(q)
jktD{
lt
2
s2(q)
jt
  
z
,
where the shrinkage term is proportional to the variance s2
jt
associated with genomic feature j in data type t. Coefficients will be
more heavily penalized for features demonstrating high variance.
Choice of Tuning Parameters
We use a cluster reproducibility index (RI) as described in [24]
for choosing the number of clusters (K) and the degree of sparsity
(l) in the genomic feature space. It entails repeatedly partitioning
the samples into a learning and a test set and evaluating the degree
of agreement between the predicted and the fitted (‘‘observed’’)
cluster assignment using an adjusted Rand index. The procedure
is depicted in Supplementary Figure S1. Values of RI close to 1
indicate perfect cluster reproducibility and values of RI close to 0
indicate poor cluster reproducibility. In this framework, the
concept of prediction error that typically applies to classification
analysis where the true cluster labels are known now becomes
relevant for clustering [26–28].
For visualization of the sample similarity matrix, Shen et al.
(2009) [17] described a cluster separability plot based on the
product matrix of the posterior mean of the latent factors. Perfect
cluster separability (non-overlapping clusters) would lead to an
exact diagonal block matrix with diagonal blocks of ones for
samples belonging to the same cluster and off-diagonal blocks of
zeros for samples in different clusters. The corresponding
proportion of deviance (POD) measure is between 0 and 1. Small
values of POD indicate strong cluster separability, and large values
of POD indicate poor cluster separability.
Sampling design
In the integrative space, an exhaustive grid search for the optimal
combination of (K,l) that maximizes cluster reproducibility is
inefficient and computationally prohibitive. To overcome this
obstacle, we use the uniform sampling design (UD) approach of
Fang and Wang (1994) [29] to generate experimental points that
scattered uniformly across the search domain. It has been shown
that UD has superior convergence rate than the traditional grid
search over the parameter space [29]. Suppose we apply iCluster on
two data types (t~1,2) with a parameter tuning process that
involves finding the best values for (l1,l2), the sparsity-inducing
penalty parameters as described earlier. Each of the penalty
parameters ranges between 0 and 1, with 0 representing the null
model where no features are selected and 1 representing the full
model where all features are included. Supplementary Figure S4
shows an example ofthe UDsampling patternwheren here denotes
the number of ‘trials’ in which we fit the iCluster model with the
chosen combinations of (l1,l2) uniformly sampled from the search
domainD. A keytheoretic advantage of the uniformdesignoverthe
traditional grid search is the uniform space filling property that
avoids wasteful computation at close-by points. As we can see in
Supplementary FigureS4,eachvalueof(l1,l2) onlyappearsoncein
the UD design, an important characteristic for efficient model
selection. The parameter points used to generate UD sampling
patterns are chosen by number-theoretic methods (Fang and
Wang,1994) that achieve uniform and space-filling properties.
The UD tables can be found at the following link: http://www.
math.hkbu.edu.hk/UniformDesign/.
Mutual information
Mutual information is a general measure of certain functional
dependence (unrestricted to linear dependence) between two
random variables. van Wieringen and van der Vaart (2011) [22]
uses mutual information to quantify the extent to which entropy
increase in one random variable (DNA copy number) leads to an
entropy increase in another (gene expression). The classic
definition of mutual information between two random variable is
I(X,Y)~
ðð
f(X,Y)(x,y)log
f(X,Y)(x,y)
f(X)(x)f(Y)y
dxdy, ð1Þ
where f(X,Y)(x,y) is the joint density function of X and Y, and
f(X)(x) and f(Y)(y) are the marginal density functions. Mutual
information of two Gaussian random variable is known to be
I(X,Y)~{
1
2
log(1{r2) where r is the correlation which is what
we used in Figure 7.
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